TRADEUP ACQUISITION CORP-CW (ESLAW:NASDAQ)
$0.122 -0.008 (-6.1538%)
Analysed TRADEUP ACQUISITION CORP-CW (ESLAW:NASDAQ) News Sources
Is Estrella Immunopharma (NASDAQ:ESLA) In A Good Position To Deliver On Growth Plans?
14-08-2025
yahoo.com
Estrella Immunopharma Regains Compliance with Nasdaq Listing Requirements
06-10-2025
yahoo.com
Estrella Immunopharma Completes Second Dose Cohort in STARLIGHT-1 Trial of EB103 with Complete Responses in All Evaluable Patients
03-11-2025
yahoo.com
Top 100 Stocks to Buy: Two Penny Stocks Moved Up 51 Spots. Should You Buy Either?
04-11-2025
barchart.com
ESLA: Initiating Coverage of Estrella Immunopharma: A Potential Successor to Arcellx in Next-Generation CAR-T
18-03-2026
yahoo.com
Estrella Immunopharma, Inc. (NASDAQ: ESLA) Receives Initiating Coverage with a Valuation of $12.00/Share from Zacks Small-Cap Research
23-03-2026
yahoo.com
Estrella Immunopharma to Participate in the D. Boral Capital Global Conference
05-05-2026
yahoo.com
What is the current price of TRADEUP ACQUISITION CORP-CW (ESLAW:NASDAQ)?
The current price of TRADEUP ACQUISITION CORP-CW (ESLAW:NASDAQ) is $0.122.
TRADEUP ACQUISITION CORP-CW (ESLAW:NASDAQ) absolute price change since previous trading day?
The absolute price change of TRADEUP ACQUISITION CORP-CW (ESLAW:NASDAQ) since the previous trading day is $-0.008.
TRADEUP ACQUISITION CORP-CW (ESLAW:NASDAQ) percentage price change since previous trading day?
The percentage price change of TRADEUP ACQUISITION CORP-CW (ESLAW:NASDAQ) since the previous trading day is -6.1538%.
What is the most recent average sentiment score for TRADEUP ACQUISITION CORP-CW (ESLAW:NASDAQ)?
The most recent average sentiment score for TRADEUP ACQUISITION CORP-CW (ESLAW:NASDAQ) is 71 out of 100.
What is the most recent average sentiment for TRADEUP ACQUISITION CORP-CW (ESLAW:NASDAQ)?
The most recent sentiment for TRADEUP ACQUISITION CORP-CW (ESLAW:NASDAQ) is .
SEC-8K** Filing Available For TRADEUP ACQUISITION CORP-CW (ESLAW:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.